糖尿病视网膜病变的危险因素与患病率：一项荟萃分析方案
Risk factors and prevalence of diabetic retinopathy: A protocol for meta-analysis.
作者信息
Hou Yuying, Cai Yitong, Jia Zhumin, Shi Suling
机构信息
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan.
The school of Nursing, Lanzhou University, Lanzhou, Gansu, China.
出版信息
Medicine (Baltimore). 2020 Oct 16;99(42):e22695. doi: 10.1097/MD.0000000000022695.
BACKGROUND
Diabetic retinopathy (DR) is one of the serious complications of diabetes mellitus. Without further treatment, it can evolve into the stage of proliferation, which will lead to the formation of new blood vessels, vitreous hemorrhage, or anterior retinal hemorrhage, which will lead to severe vision loss and increase the risk of blindness.
METHODS
The research literature on the risk factors of diabetic retinopathy published as of July 1, 2020 was searched through MEDLINE, Embase, ovid, Web of Science, Wanfang, CNKI, and other databases, The search strategy has been first developed in MEDLINE using MeSH subject headings combined with free-text terms and Stata12.0 software was used for meta-analysis.
RESULTS
This study is ongoing and the results will be submitted to a peer-reviewed journal for publication.
ETHICS AND DISSEMINATION
Ethical approval is not applicable, since this is an overview based on published articles.
PROTOCOL REGISTRATION NUMBER
The registration number is INPLASY202070107, the DOI number is 10.37766/inplasy2020.7.0107.
背景
糖尿病视网膜病变（DR）是糖尿病的严重并发症之一。若不进一步治疗，其可发展为增殖期，进而导致新生血管形成、玻璃体积血或视网膜前出血，最终导致严重视力丧失并增加失明风险。
方法
通过MEDLINE、Embase、ovid、Web of Science、万方、知网等数据库检索截至2020年7月1日发表的关于糖尿病视网膜病变危险因素的研究文献。检索策略首先在MEDLINE中使用医学主题词（MeSH）结合自由文本词制定，并用Stata12.0软件进行荟萃分析。
结果
本研究正在进行中，结果将提交给同行评审期刊发表。
伦理与传播
由于本研究是基于已发表文章的综述，因此无需伦理批准。
方案注册号
注册号为INPLASY202070107，数字对象标识符（DOI）编号为10.37766/inplasy2020.7.0107。
Zotero 插件